These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 30756134)

  • 1. Targeting the immune system in the treatment of bipolar disorder.
    Rosenblat JD
    Psychopharmacology (Berl); 2019 Oct; 236(10):2909-2921. PubMed ID: 30756134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-inflammatory agents in the treatment of bipolar depression: a systematic review and meta-analysis.
    Rosenblat JD; Kakar R; Berk M; Kessing LV; Vinberg M; Baune BT; Mansur RB; Brietzke E; Goldstein BI; McIntyre RS
    Bipolar Disord; 2016 Mar; 18(2):89-101. PubMed ID: 26990051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Taking the fuel out of the fire: evidence for the use of anti-inflammatory agents in the treatment of bipolar disorders.
    Ayorech Z; Tracy DK; Baumeister D; Giaroli G
    J Affect Disord; 2015 Mar; 174():467-78. PubMed ID: 25553408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic implications of inflammatory comorbidity in bipolar disorder.
    Rosenblat JD; Gregory JM; McIntyre RS
    Curr Opin Pharmacol; 2016 Aug; 29():63-9. PubMed ID: 27400335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammation as a neurobiological substrate of cognitive impairment in bipolar disorder: Evidence, pathophysiology and treatment implications.
    Rosenblat JD; Brietzke E; Mansur RB; Maruschak NA; Lee Y; McIntyre RS
    J Affect Disord; 2015 Dec; 188():149-59. PubMed ID: 26363613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bipolar Disorder and Inflammation.
    Rosenblat JD; McIntyre RS
    Psychiatr Clin North Am; 2016 Mar; 39(1):125-37. PubMed ID: 26876323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Non-conventional pharmacological agents for the treatment of bipolar disorder: Α systematic review of the evidence].
    Fountoulakis KN; Balaris D; Nikolaou V; Νimatoudis J
    Psychiatriki; 2016; 27(4):253-263. PubMed ID: 28114089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune-based strategies for mood disorders: facts and challenges.
    Colpo GD; Leboyer M; Dantzer R; Trivedi MH; Teixeira AL
    Expert Rev Neurother; 2018 Feb; 18(2):139-152. PubMed ID: 29179585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacotherapeutic value of inflammatory and neurotrophic biomarkers in bipolar disorder: A systematic review.
    Ruiz-Sastre P; Gómez-Sánchez-Lafuente C; Martín-Martín J; Herrera-Imbroda J; Mayoral-Cleries F; Santos-Amaya I; Rodríguez de Fonseca F; Guzmán-Parra J; Rivera P; Suárez J
    Prog Neuropsychopharmacol Biol Psychiatry; 2024 Aug; 134():111056. PubMed ID: 38879067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are medical comorbid conditions of bipolar disorder due to immune dysfunction?
    Rosenblat JD; McIntyre RS
    Acta Psychiatr Scand; 2015 Sep; 132(3):180-91. PubMed ID: 25772638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polarity index of pharmacological agents used for maintenance treatment of bipolar disorder.
    Popovic D; Reinares M; Goikolea JM; Bonnin CM; Gonzalez-Pinto A; Vieta E
    Eur Neuropsychopharmacol; 2012 May; 22(5):339-46. PubMed ID: 22000157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjunctive nutraceuticals with standard pharmacotherapies in bipolar disorder: a systematic review of clinical trials.
    Sarris J; Mischoulon D; Schweitzer I
    Bipolar Disord; 2011; 13(5-6):454-65. PubMed ID: 22017215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pilot, open-label, 8-week study evaluating the efficacy, safety and tolerability of adjunctive minocycline for the treatment of bipolar I/II depression.
    Soczynska JK; Kennedy SH; Alsuwaidan M; Mansur RB; Li M; McAndrews MP; Brietzke E; Woldeyohannes HO; Taylor VH; McIntyre RS
    Bipolar Disord; 2017 May; 19(3):198-213. PubMed ID: 28599348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Double-Blind, Randomized, Placebo-Controlled Study of Aspirin and N-Acetylcysteine as Adjunctive Treatments for Bipolar Depression.
    Bauer IE; Green C; Colpo GD; Teixeira AL; Selvaraj S; Durkin K; Zunta-Soares GB; Soares JC
    J Clin Psychiatry; 2018 Dec; 80(1):. PubMed ID: 30549489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative efficacy, acceptability, and tolerability of adjunctive anti-inflammatory agents on bipolar disorder: A systemic review and network meta-analysis.
    Xu H; Du Y; Wang Q; Chen L; Huang J; Liu Y; Zhou C; Du B
    Asian J Psychiatr; 2023 Feb; 80():103394. PubMed ID: 36525766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A systematic review of evidence for the role of inflammatory biomarkers in bipolar patients.
    Sayana P; Colpo GD; Simões LR; Giridharan VV; Teixeira AL; Quevedo J; Barichello T
    J Psychiatr Res; 2017 Sep; 92():160-182. PubMed ID: 28458141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxcarbazepine for acute affective episodes in bipolar disorder.
    Vasudev A; Macritchie K; Vasudev K; Watson S; Geddes J; Young AH
    Cochrane Database Syst Rev; 2011 Dec; (12):CD004857. PubMed ID: 22161387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-inflammatory treatments for mood disorders: Systematic review and meta-analysis.
    Husain MI; Strawbridge R; Stokes PR; Young AH
    J Psychopharmacol; 2017 Sep; 31(9):1137-1148. PubMed ID: 28858537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel therapeutic targets in mood disorders: Pentoxifylline (PTX) as a candidate treatment.
    Siegel AN; Rodrigues N; Nasri F; Wilkialis L; Lipsitz O; Lee Y; Gill H; Subramaniapillai M; Phan L; Majeed A; Lui LMW; Rashidian H; Ho R; Toma S; Goldstein BI; Mansur RB; McIntyre RS; Rosenblat JD
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jan; 104():110032. PubMed ID: 32634540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of mood-stabilizing drugs on cytokine levels in bipolar disorder: A systematic review.
    van den Ameele S; van Diermen L; Staels W; Coppens V; Dumont G; Sabbe B; Morrens M
    J Affect Disord; 2016 Oct; 203():364-373. PubMed ID: 27344047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.